Alkem Lab
₹5,250
- Market Cap
- ₹60,322Cr.
- P/E Ratio
- 26.5
- P/B Ratio
- 4.54
- EPS (TTM)
- ₹198.11
- Div Yield
- 1.01%
- ROCE
- 21.2%
- ROE
- 18.9%
52W Low: ₹5,04252W High: ₹5,934
Themes:💊 Pharma & CDMO
Appears in 1 screen
Descriptive screens built from published data — not investment advice.
At a glance
- Sales have grown 8.0% a year over three years.
- Debt is 0.15× its shareholders’ equity.
From reported financials and exchange prices. Descriptive only, not advice.
Alkem_Lab — Price
Interval
Style
Failed: 503
Scorecard
Market: risk-off · breadth 371/8Minerviniuptrend checks met
39RS Rankvs all stocks, 1–99
bearRSI Regimemomentum range
15Trend (ADX)trend strength
0/4CAN SLIMprice & volume checks
upSupertrendprice vs trailing line
downVolume Flowbuying vs selling volume
Factual technical classifications from price/volume data — research signals, not investment advice. Hover or tap any badge for what it means.
Evenstocks Score
Middle third
Overall
Valuation
Quality
Fundamental
Growth
Investment Checklist
Quick assessment based on key parametersPerformance
N/ATrailing return unavailableValuation
P/E 26.5P/E: 26.5 | P/B: 4.54Growth
ModestSales CAGR — 3Y: 8% · 1Y: 13%Profitability
High MarginROCE: 21.2% | ROE: 18.9%Key Metrics
Valuation
PEG Ratio 0.83
Price / Sales 4.00x
Price / FCF 40.9x
Book Value ₹1156
Margins & returns
Operating Margin 20%
Net Margin 14.6%
Return on Assets 10.6%